Talphera Inc. will host a virtual investor and analyst conference call and webcast on March 23, 2026 at 11:00 a.m. ET featuring nephrologists Dr. Blaithin McMahon and Dr. Joao Teixeira, who will discuss their experience with continuous renal replacement therapy (CRRT) and current anticoagulant use, and take investor questions. Event materials can be accessed via https://www.talphera.com and the webcast link in the Investors/News & Events/Upcoming Events section.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF98684) on March 02, 2026, and is solely responsible for the information contained therein.
Comments